Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke |
Kim, Jeong-Hyeon
(College of Pharmacy, Hanyang University)
Byun, Hyeong-Min (College of Pharmacy, Hanyang University) Chung, Eui-Cheol (College of Pharmacy, Hanyang University) Chung, Han-Young (Department of Biotechnology and Bioinformatics, Korea University) Bae, Ok-Nam (College of Pharmacy, Hanyang University) |
1 | Elliott, P., Arnold, R., Cockings, S., Eaton, N., Jarup, L., Jones, J., Quinn, M., Rosato, M., Thornton, I., Toledano, M., Tristan, E. and Wakefield, J. (2000) Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup. Environ. Med., 57, 94-97. DOI ScienceOn |
2 | Moller, L. and Kristensen, T.S. (1992) Blood lead as a cardiovascular risk factor. Am. J. Epidemiol., 136, 1091-1100. DOI |
3 | Schober, S.E., Mirel, L.B., Graubard, B.I., Brody, D.J. and Flegal, K.M. (2006) Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ. Health Perspect., 114, 1538-1541. |
4 | Navas-Acien, A., Selvin, E., Sharrett, A.R., Calderon-Aranda, E., Silbergeld, E. and Guallar, E. (2004) Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation, 109, 3196-3201. DOI ScienceOn |
5 | Menke, A., Muntner, P., Batuman, V., Silbergeld, E.K. and Guallar, E. (2006) Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation, 114, 1388-1394. DOI ScienceOn |
6 | Lustberg, M. and Silbergeld, E. (2002) Blood lead levels and mortality. Arch. Intern. Med., 162, 2443-2449. DOI ScienceOn |
7 | Peters, J.L., Perlstein, T.S., Perry, M.J., Mcneely, E. and Weuve, J. (2010) Cadmium exposure in association with history of stroke and heart failure. Environ. Res., 110, 199-206. DOI ScienceOn |
8 | Garcia Gomez, M., Boffetta, P., Caballero Klink, J.D., Espanol, S. and Gomez Quintana, J. (2007) [Cardiovascular mortality in mercury miners]. Med. Clin. (Barcelona), 128, 766-771. DOI |
9 | Lisabeth, L.D., Ahn, H.J., Chen, J.J., Sealy-Jefferson, S., Burke, J.F. and Meliker, J.R. (2010) Arsenic in drinking water and stroke hospitalizations in Michigan. Stroke, 41, 2499-2504. DOI ScienceOn |
10 | Chiou, H.Y., Huang, W.I., Su, C.L., Chang, S.F., Hsu, Y.H. and Chen, C.J. (1997) Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke, 28, 1717-1723. DOI ScienceOn |
11 | Dietrich, W.D., Alonso, O. and Busto, R. (1993) Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke, 24, 111-116. DOI ScienceOn |
12 | Chi, O.Z., Hunter, C., Liu, X. and Weiss, H.R. (2009) Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia. Neurochem. Res., 34, 1249-1254. DOI ScienceOn |
13 | Zheng, W., Aschner, M. and Ghersi-Egea, J.F. (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol. Appl. Pharmacol., 192, 1-11. DOI ScienceOn |
14 | Goldstein, G.W., Asbury, A.K. and Diamond, I. (1974) Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch. Neurol., 31, 382-389. DOI ScienceOn |
15 | Struzynska, L., Walski, M., Gadamski, R., Dabrowska-Bouta, B. and Rafalowska, U. (1997) Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol. Chem. Neuropathol., 31, 207-224. DOI |
16 | Toews, A.D., Kolber, A., Hayward, J., Krigman, M.R. and Morell, P. (1978) Experimental lead encephalopathy in the suckling rat: concentration of lead in cellular fractions enriched in brain capillaries. Brain Res., 147, 131-138. DOI ScienceOn |
17 | Dyatlov, V.A., Platoshin, A.V., Lawrence, D.A. and Carpenter, D.O. (1998) Lead potentiates cytokine- and glutamatemediated increases in permeability of the blood-brain barrier. Neurotoxicology, 19, 283-291. |
18 | Shukla, A., Shukla, G.S. and Srimal, R.C. (1996) Cadmiuminduced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in rat. Hum. Exp. Toxicol., 15, 400-405. DOI ScienceOn |
19 | Jeong, E.M., Moon, C.H., Kim, C.S., Lee, S.H., Baik, E.J., Moon, C.K. and Jung, Y.S. (2004) Cadmium stimulates the expression of ICAM-1 via NF-kappaB activation in cerebrovascular endothelial cells. Biochem. Biophys. Res. Commun., 320, 887-892. DOI ScienceOn |
20 | Jung, Y.S., Jeong, E.M., Park, E.K., Kim, Y.M., Sohn, S., Lee, S.H., Baik, E.J. and Moon, C.H. (2008) Cadmium induces apoptotic cell death through p38 MAPK in brain microvessel endothelial cells. Eur. J. Pharmacol., 578, 11-18. DOI ScienceOn |
21 | Clarkson, T.W. (1993) Mercury: major issues in environmental health. Environ. Health Perspect., 100, 31-38. DOI |
22 | Peterson, E.W. and Cardoso, E.R. (1983) The blood-brain barrier following experimental subarachnoid hemorrhage. Part 2: Response to mercuric chloride infusion. J. Neurosurg., 58, 345-351. DOI |
23 | Chiou, J.M., Wang, S.L., Chen, C.J., Deng, C.R., Lin, W. and Tai, T.Y. (2005) Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol., 34, 936-943. DOI ScienceOn |
24 | Chen, S.C., Tsai, M.H., Wang, H.J., Yu, H.S. and Chang, L.W. (2004) Vascular permeability alterations induced by arsenic. Hum. Exp. Toxicol., 23, 1-7. DOI |
25 | Reyes, J.L., Molina-Jijon, E., Rodriguez-Munoz, R., Bautista-Garcia, P., Debray-Garcia, Y. and Namorado Mdel, C. (2013) Tight junction proteins and oxidative stress in heavy metalsinduced nephrotoxicity. Biomed. Res. Int., 2013, 730789. |
26 | Wong, E.W. and Cheng, C.Y. (2011) Impacts of environmental toxicants on male reproductive dysfunction. Trends Pharmacol. Sci., 32, 290-299. DOI ScienceOn |
27 | Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Makuc, D.M., Marcus, G.M., Marelli, A., Matchar, D.B., Moy, C.S., Mozaffarian, D., Mussolino, M.E., Nichol, G., Paynter, N.P., Soliman, E.Z., Sorlie, P.D., Sotoodehnia, N., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2012) Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation, 125, e2-e220. DOI |
28 | O'Donnell, M.J., Xavier, D., Liu, L., Zhang, H., Chin, S.L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., Mcqueen, M.J., Mondo, C., Damasceno, A., Lopez-Jaramillo, P., Hankey, G.J., Dans, A.L., Yusoff, K., Truelsen, T., Diener, H.C., Sacco, R.L., Ryglewicz, D., Czlonkowska, A., Weimar, C., Wang, X., Yusuf, S. and Investigators, I. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet, 376, 112-123. DOI ScienceOn |
29 | Fisher, M. (2011) New approaches to neuroprotective drug development. Stroke, 42, S24-S27. DOI ScienceOn |
30 | Savitz, S.I. and Fisher, M. (2007) Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann. Neurol., 61, 396-402. DOI ScienceOn |
31 | Lo, E.H., Dalkara, T. and Moskowitz, M.A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci., 4, 399-415. |
32 | Dirnagl, U., Iadecola, C. and Moskowitz, M.A. (1999) Patho-biology of ischaemic stroke: an integrated view. Trends Neurosci., 22, 391-397. DOI ScienceOn |
33 | Macdonald, J.F., Xiong, Z.G. and Jackson, M.F. (2006) Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci., 29, 75-81. DOI ScienceOn |
34 | Graham, S.H. and Chen, J. (2001) Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab., 21, 99-109. DOI |
35 | Lo, E.H., Moskowitz, M.A. and Jacobs, T.P. (2005) Exciting, radical, suicidal: how brain cells die after stroke. Stroke, 36, 189-192. DOI ScienceOn |
36 | Green, A.R. (2008) Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br. J. Pharmacol., 153 Suppl 1, S325-S338. |
37 | del Zoppo, G.J. (2006) Stroke and neurovascular protection. N. Engl. J. Med., 354, 553-555. DOI ScienceOn |
38 | Wolburg, H. and Lippoldt, A. (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol., 38, 323-337. DOI ScienceOn |
39 | Ballabh, P., Braun, A. and Nedergaard, M. (2004) The bloodbrain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis., 16, 1-13. DOI ScienceOn |
40 | Lai, C.H., Kuo, K.H. and Leo, J.M. (2005) Critical role of actin in modulating BBB permeability. Brain Res. Brain Res. Rev., 50, 7-13. DOI ScienceOn |
41 | Matter, K. and Balda, M.S. (2003) Signalling to and from tight junctions. Nat. Rev. Mol. Cell Biol., 4, 225-236. DOI ScienceOn |
42 | Hawkins, B.T. and Davis, T.P. (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev., 57, 173-185. DOI ScienceOn |
43 | Oldendorf, W.H., Cornford, M.E. and Brown, W.J. (1977) The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann. Neurol., 1, 409-417. DOI ScienceOn |
44 | del Zoppo, G.J. and Mabuchi, T. (2003) Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab., 23, 879-894. DOI |
45 | Petty, M.A. and Wettstein, J.G. (2001) Elements of cerebral microvascular ischaemia. Brain Res. Brain Res. Rev., 36, 23-34. DOI ScienceOn |
46 | Mark, K.S. and Davis, T.P. (2002) Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am. J. Physiol. Heart Circ. Physiol., 282, H1485-H1494. DOI |
47 | Denes, A., Ferenczi, S. and Kovacs, K.J. (2011) Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, bloodbrain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation, 8, 164. DOI |
48 | Strbian, D., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., Abo-Ramadan, U. and Tatlisumak, T. (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience, 153, 175-181. DOI ScienceOn |
49 | Kahles, T., Luedike, P., Endres, M., Galla, H.J., Steinmetz, H., Busse, R., Neumann-Haefelin, T. and Brandes, R.P. (2007) NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke, 38, 3000-3006. DOI ScienceOn |
50 | Belayev, L., Busto, R., Zhao, W. and Ginsberg, M.D. (1996) Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res., 739, 88-96. DOI ScienceOn |
51 | Abo-Ramadan, U., Durukan, A., Pitkonen, M., Marinkovic, I., Tatlisumak, E., Pedrono, E., Soinne, L., Strbian, D. and Tatlisumak, T. (2009) Post-ischemic leakiness of the bloodbrain barrier: a quantitative and systematic assessment by Patlak plots. Exp. Neurol., 219, 328-333. DOI ScienceOn |
52 | Sandoval, K.E. and Witt, K.A. (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis., 32, 200-219. DOI ScienceOn |
53 | Rosenberg, G.A., Estrada, E.Y. and Dencoff, J.E. (1998) Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke, 29, 2189-2195. DOI ScienceOn |
54 | Ramos-Fernandez, M., Bellolio, M.F. and Stead, L.G. (2011) Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J. Stroke Cerebrovasc. Dis., 20, 47-54. DOI ScienceOn |
55 | Cunningham, L.A., Wetzel, M. and Rosenberg, G.A. (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glial, 50, 329-339. DOI ScienceOn |
56 | Fischer, S., Wobben, M., Marti, H.H., Renz, D. and Schaper, W. (2002) Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc. Res., 63, 70-80. DOI ScienceOn |
57 | Koto, T., Takubo, K., Ishida, S., Shinoda, H., Inoue, M., Tsubota, K., Okada, Y. and Ikeda, E. (2007) Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am. J. Pathol., 170, 1389-1397. DOI ScienceOn |
58 | Song, L., Ge, S. and Pachter, J.S. (2007) Caveolin-1 regulates expression of junction-associated proteins in brain microvascular endothelial cells. Blood, 109, 1515-1523. DOI ScienceOn |
59 | Liu, J., Jin, X., Liu, K.J. and Liu, W. (2012) Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J. Neurosci., 32, 3044-3057. DOI |
60 | Andras, I.E., Deli, M.A., Veszelka, S., Hayashi, K., Hennig, B. and Toborek, M. (2007) The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J. Cereb. Blood Flow Metab., 27, 1431-1443. DOI ScienceOn |
61 | Zlokovic, B.V. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 57, 178-201. DOI ScienceOn |
62 | Gasche, Y., Copin, J.C., Sugawara, T., Fujimura, M. and Chan, P.H. (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab., 21, 1393-1400. DOI |
63 | Heo, J.H., Han, S.W. and Lee, S.K. (2005) Free radicals as triggers of brain edema formation after stroke. Free Radical Biol. Med., 39, 51-70. DOI ScienceOn |
64 | Fagan, S.C., Hess, D.C., Hohnadel, E.J., Pollock, D.M. and Ergul, A. (2004) Targets for vascular protection after acute ischemic stroke. Stroke, 35, 2220-2225. DOI ScienceOn |
65 | Rosenberg, G.A. and Yang, Y. (2007) Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cere bral ischemia. Neurosurg. Focus, 22, E4. |
66 | Kastrup, A., Groschel, K., Ringer, T.M., Redecker, C., Cordesmeyer, R., Witte, O.W. and Terborg, C. (2008) Early disruption of the blood-brain barrier after thrombolytic therapy predicts hemorrhage in patients with acute stroke. Stroke, 39, 2385-2387. DOI ScienceOn |
67 | Krysl, D., Deykun, K., Lambert, L., Pokorny, J. and Mares, J. (2012) Perifocal and remote blood-brain barrier disruption in cortical photothrombotic ischemic lesion and its modulation by the choice of anesthesia. J. Physiol. Pharmacol., 63, 127-132. |
68 | Ivens, S., Kaufer, D., Flores, L.P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U. and Friedman, A. (2007) TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain, 130, 535-547. DOI ScienceOn |
69 | Seiffert, E., Dreier, J.P., Ivens, S., Bechmann, I., Tomkins, O., Heinemann, U. and Friedman, A. (2004) Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci., 24, 7829-7836. DOI ScienceOn |
70 | Bernal-Pacheco, O. and Roman, G.C. (2007) Environmental vascular risk factors: new perspectives for stroke prevention. J. Neurol. Sci., 262, 60-70. DOI ScienceOn |
71 | Mateen, F.J. and Brook, R.D. (2011) Air pollution as an emerging global risk factor for stroke. JAMA, 305, 1240-1241. DOI ScienceOn |
72 | Kromhout, D. (1988) Blood lead and coronary heart disease risk among elderly men in Zutphen, The Netherlands. Environ. Health Perspect., 78, 43-46. DOI ScienceOn |
![]() |